Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis
Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused significant health and economic havoc around the globe. One of the early agents targeted for repurposing to treat and prevent COVID-19 was hydroxychloroquine (HCQ). In this systemati...
Main Authors: | Thomas S. Hong, Jimmy Gonzalez, Ronald G. Nahass, Luigi Brunetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/8/4/208 |
Similar Items
-
Use of chloroquine and hydroxychloroquine in COVID-19 patients: A dilemma
by: Archana Bhatia, et al.
Published: (2022-01-01) -
Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?
by: Syed Shahzad Hasan, et al.
Published: (2020-03-01) -
Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine
by: Tomohiro Tanaka, et al.
Published: (2023-03-01) -
Hydroxychloroquine for the treatment of COVID-19: an approach based on the philosophy of science and heuristics
by: Davi Jorge Fontoura Solla
Published: (2020-05-01) -
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)